Shareholders approve extension of business combination deadline to Nov 2022

Orchestra BioMed Holdings, Inc.

Extension Proposal approved: 15,084,246 for, 1,365,812 against, 0 abstain.
Deadline extended from Aug 6, 2022 to Nov 6, 2022, with option for monthly extensions to Feb 6, 2023.
Proxies received for 80.4% of 20,450,000 outstanding shares, quorum present.
Adjournment Proposal not needed due to sufficient votes for Extension Proposal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.